Avid Bioservices, Inc. - stock earnings
CDMO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -2.1 million USD | 37.7 million USD |
| 2023Q2 | -309000 USD | 39.8 million USD |
| 2023Q1 | 461000 USD | 38.0 million USD |
| 2022Q4 | -1.2 million USD | 34.8 million USD |
| 2022Q3 | 1.6 million USD | 36.7 million USD |
| 2022Q2 | 115.6 million USD | 31.2 million USD |
| 2022Q1 | 2.2 million USD | 31.5 million USD |
| 2021Q4 | 3.5 million USD | 26.1 million USD |
| 2021Q3 | 6.3 million USD | 30.8 million USD |
| 2021Q2 | 2.0 million USD | 27.6 million USD |
| 2021Q1 | 2.2 million USD | 21.8 million USD |
| 2020Q4 | 2.3 million USD | 21.1 million USD |
| 2012Q4 | ? USD | 6.1 million USD |
CDMO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 560000 USD | 149.3 million USD |
| 2022 | 127.7 million USD | 119.6 million USD |
| 2021 | 11.2 million USD | 95.9 million USD |
| 2020 | -7.3 million USD | 59.7 million USD |
| 2019 | -4.2 million USD | 53.6 million USD |
| 2018 | -21.8 million USD | 53.6 million USD |
| 2017 | -28.2 million USD | 57.6 million USD |
| 2016 | -55.7 million USD | 44.7 million USD |
| 2015 | -50.4 million USD | 26.8 million USD |
| 2014 | -35.4 million USD | 22.4 million USD |
| 2013 | -29.8 million USD | 21.7 million USD |
| 2012 | -42.1 million USD | 15.2 million USD |
| 2011 | -34.2 million USD | 13.5 million USD |
| 2010 | -14.5 million USD | 27.9 million USD |
| 2009 | -16.5 million USD | 18.2 million USD |
| 2008 | -23.2 million USD | 6.1 million USD |
| 2007 | -20.8 million USD | 3.7 million USD |
| 2006 | -17.1 million USD | 3.2 million USD |
| 2005 | -15.5 million USD | 5.0 million USD |
| 2004 | -14.3 million USD | 3.3 million USD |
| 2003 | -11.6 million USD | 3.9 million USD |
| 2002 | -11.7 million USD | 3.8 million USD |
| 2001 | -9.5 million USD | 979000 USD |
| 2000 | -14.5 million USD | 1000 USD |
| 1999 | -19.5 million USD | 100000 USD |
| 1998 | -11.8 million USD | 500000 USD |
| 1997 | -33.2 million USD | 300000 USD |
| 1996 | 300000 USD | 3.1 million USD |
| 1995 | -6.9 million USD | 100000 USD |
CDMO
Price: $7.67
52 week price:
Earnings Per Share: -0.18 USD
P/E Ratio: -36.78
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 451500
Ebitda: -12.0 millionMarket Capitalization: 436.4 million